UnitedHealth Group Incorporated (NYSE:UNH) Stake Raised by Orrstown Financial Services Inc.

Orrstown Financial Services Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,954 shares of the healthcare conglomerate’s stock after buying an additional 47 shares during the period. UnitedHealth Group accounts for about 0.8% of Orrstown Financial Services Inc.’s investment portfolio, making the stock its 15th biggest holding. Orrstown Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,461,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Bell Investment Advisors Inc grew its position in UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 24 shares during the last quarter. Verdence Capital Advisors LLC grew its position in UnitedHealth Group by 2.1% in the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after buying an additional 342 shares during the last quarter. Bellecapital International Ltd. grew its position in UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after buying an additional 193 shares during the last quarter. Rise Advisors LLC grew its position in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after purchasing an additional 163 shares in the last quarter. Finally, Gradient Investments LLC grew its position in UnitedHealth Group by 6.3% during the 4th quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after purchasing an additional 5,023 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.7 %

UnitedHealth Group stock opened at $481.05 on Thursday. The firm has a market cap of $442.75 billion, a price-to-earnings ratio of 29.40, a P/E/G ratio of 1.40 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The firm has a fifty day moving average price of $495.26 and a two-hundred day moving average price of $504.85.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the business earned $6.26 EPS. The business’s revenue was up 8.6% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be issued a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.75%. UnitedHealth Group’s payout ratio is presently 51.34%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research report on Wednesday, June 5th. Robert W. Baird initiated coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective on the stock. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Finally, Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.